Nuvectis Pharma Inc. (NVCT)
undefined
undefined%
At close: undefined
4.70
-0.69%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -22.26M -19.09M -12.89M -24.00K
Depreciation & Amortization - - - -
Stock-Based Compensation 4.71M 1.71M 1.89M -
Other Working Capital 1.88M -321.00K -91.00K 10.00K
Other Non-Cash Items -139.00K -2.43M 307.00K 24.00K
Deferred Income Tax - - - -
Change in Working Capital 1.74M 3.82M 1.49M 10.00K
Operating Cash Flow -15.95M -13.56M -9.50M 24.00K
Capital Expenditures - - - -
Acquisitions - - - -
Purchase of Investments - - - -
Sales Maturities Of Investments - - - -
Other Investing Acitivies - - - -
Investing Cash Flow - - - -
Debt Repayment - - - -
Common Stock Repurchased - - - -
Dividend Paid - - - -
Other Financial Acitivies 9.80M -4.07M 15.25M -
Financial Cash Flow 15.09M 27.81M 15.25M -
Net Cash Flow -867.00K 14.25M 5.74M 24.00K
Free Cash Flow -15.95M -13.56M -9.50M 24.00K